ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Deputy Director Ihde To Leave Institute; Bynum To Retire; Lewis Thomas Dead At 80

December 10, 1993

DCBD Board Okays New Program Projects For Diagnosis Research

June 7, 1985

Court Agreement Clears The Way For Human Gene Transplant Study

May 26, 1989

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007

Neurosurgeons Say They Wouldn’t Step Into The MRI Van; Should An Asymptomatic Editor?

May 8, 2009

Avon 1995 Grant Application Available

December 2, 1994